BioMarin resubmits haemophilia A gene therapy to the EMA
29th June 2021 Uncategorised 0Company initially withdrew a marketing authorisation application for the gene therapy last year
More: BioMarin resubmits haemophilia A gene therapy to the EMA
Source: News
